Xenon Pharmaceuticals (XENE) Stock: Buy, Sell, or Hold?
XENE - Xenon Pharmaceuticals Inc
$38.93
1.74 (4.68%)
▲
5d:
+2.29%
30d:
-35.12%
90d:
-36.14%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 02, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 22, 2026 at $39.09 · last confirmed Oct 1, 2026
Strength: 5.6/10
Get Alerted When XENE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XENE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XENE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XENE is currently trading at $38.93, which is considered oversold relative to its 30-day fair value range of $41.39 to $62.29.
Technical Outlook: Technically, XENE is showing sideways momentum. Immediate support is located at $36.07, while resistance sits at $44.85. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: XENE scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $74.31 (+90.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XENE is showing sideways momentum. Immediate support is located at $36.07, while resistance sits at $44.85. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: XENE scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $74.31 (+90.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$41.39 -
$62.29
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
Protect Your Profits
Holding XENE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.7%)
- BULLISH: Trading 90.9% below Wall St target ($74.31)
- CAUTION: Bottoming setup, but lagging the sector by 47% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$41.39 -
$62.29
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$36.07
Resistance Level
$44.85
Current Trend
Sideways
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.26
Wall Street Target
$74.31
(+90.9%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 01, 2026 5:39 PM ET
Data refreshes hourly during market hours. Next update: 6:39 PM
Data refreshes hourly during market hours. Next update: 6:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XENE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 47 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 52 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$310 | 69 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$63 | 59 HOLD |
Advanced XENE Option Strategies
Professional options setups generated by AI based on today's XENE price and gamma walls.